HEALTH — Nightingale Health Oyj Share Price
- €173.76m
- €110.36m
- €4.36m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.1 | ||
Price to Tang. Book | 2.5 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 39.87 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -22.16% | ||
Return on Equity | -19.38% | ||
Operating Margin | -426.62% |
Financial Summary
Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | 1.78 | 2.31 | 2.31 | 4.18 | 4.36 | 5 | 8 | 16.13% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Nightingale Health Oyj is a Finland-based health technology company whose mission is to build sustainable healthcare and reduce health inequalities. It has developed an advanced health check that provides risk detection for multiple chronic diseases from a single blood sample. The blood analysis technology developed by Nightingale measures a broad group of biomarkers from a single blood sample, recognizing individual disease risks. The Company provides people with comprehensive insights on health, helps them make better decisions regarding their health and connects them with healthcare experts that offer preventative services for maintaining health. Nightingale Health Oy is the Parent Company in the Nightingale Group. The Company has subsidiaries in the United Kingdom, Japan, Sweden, Germany, Singapore, Estonia and the United States.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- March 28th, 2002
- Public Since
- March 19th, 2021
- No. of Shareholders
- 11,659
- No. of Employees
- 86
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
OMX Nordic Exchange - Helsinki
- Shares in Issue
- 60,754,635

- Address
- Mannerheimintie 164a, HELSINKI, 00300
- Web
- https://nightingalehealth.com/
- Phone
- +358 207301810
- Auditors
- PricewaterhouseCoopers Oy
Upcoming Events for HEALTH
Similar to HEALTH
Herantis Pharma Oyj
OMX Nordic Exchange - Helsinki
Nanoform Finland Oyj
OMX Nordic Exchange - Helsinki
Solar Foods Oyj
OMX Nordic Exchange - Helsinki
FAQ
As of Today at 04:17 UTC, shares in Nightingale Health Oyj are trading at €2.86. This share price information is delayed by 15 minutes.
Shares in Nightingale Health Oyj last closed at €2.86 and the price had moved by +47.04% over the past 365 days. In terms of relative price strength the Nightingale Health Oyj share price has outperformed the FTSE Global All Cap Index by +43.36% over the past year.
The overall consensus recommendation for Nightingale Health Oyj is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreNightingale Health Oyj does not currently pay a dividend.
Nightingale Health Oyj does not currently pay a dividend.
Nightingale Health Oyj does not currently pay a dividend.
To buy shares in Nightingale Health Oyj you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €2.86, shares in Nightingale Health Oyj had a market capitalisation of €173.76m.
Here are the trading details for Nightingale Health Oyj:
- Country of listing: Finland
- Exchange: HEX
- Ticker Symbol: HEALTH
Based on an overall assessment of its quality, value and momentum Nightingale Health Oyj is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Nightingale Health Oyj is €2.00. That is 30.07% below the last closing price of €2.86.
Analysts covering Nightingale Health Oyj currently have a consensus Earnings Per Share (EPS) forecast of -€0.27 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nightingale Health Oyj. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -1.85%.
As of the last closing price of €2.86, shares in Nightingale Health Oyj were trading -2.32% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Nightingale Health Oyj PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €2.86.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Nightingale Health Oyj's directors